The Trump administration launched TrumpRx.gov to connect consumers with discounted prescription drugs. The initiative aims to reduce costs and expand access outside traditional insurance models.
Posts published in “Coronavirus”
Health experts say the Nipah virus poses limited global risk for now. Concerns grow over potential lab manipulation increasing its pandemic threat.
Researchers published a major review outlining biological mechanisms by which aluminum adjuvants in vaccines may contribute to autism in genetically susceptible children.
A lawsuit against the American Academy of Pediatrics is reviving controversy over its claim that infants could theoretically respond to 10,000 vaccines at once. Critics argue the argument avoided addressing cumulative safety concerns in the childhood vaccine schedule.
Authorities are investigating a possible biological laboratory discovered in a Las Vegas home linked to an illegal Chinese-run lab in California. The earlier facility contained unlabeled vials and pathogens including HIV, malaria, and dengue fever.
New DOJ-released Epstein files reveal a long-built financial and institutional architecture that treated pandemics as investable, profit-generating events years before COVID-19. The documents trace how capital, simulations, reinsurance, and vaccine pipelines converged through a small, powerful network.
Patients report they were never warned about severe risks linked to SSRI antidepressants, including withdrawal, emotional numbness, sexual dysfunction, and psychosis. Growing evidence challenges long-standing claims of safety promoted by regulators and drug manufacturers.
California is auditing hundreds of schools with vaccination rates below 95% and threatening to withhold attendance-based funding. Critics argue the policy uses financial pressure to enforce compliance rather than address public health concerns.
Health Secretary Robert F. Kennedy Jr. appointed 21 new members to the federal autism advisory committee, signaling a renewed focus on unanswered questions surrounding autism. The group aims to examine causes, treatment, prevention, and long-standing research failures.
Factory farms exploit regulatory loopholes to transfer massive amounts of manure to unregulated fields, allowing pollution to reach U.S. waterways with little oversight. The practice, known as manifesting, shields agribusinesses from accountability.
Children’s Health Defense has asked a federal court for an emergency order allowing two New York teens to remain in school while a lawsuit challenges the state’s repeal of religious vaccine exemptions. The case highlights alleged harm to disabled and vulnerable students excluded from classrooms.
Vaccine industry leaders are blaming Health Secretary Robert F. Kennedy Jr. for falling sales, stock declines, and stalled investment in new vaccines. Executives say increased scrutiny of vaccine safety has disrupted long-standing approval and rollout expectations.
A newly published case study links a tetanus-diphtheria booster to the onset of a rare autoimmune blood disorder in a previously healthy adult. Researchers say the case highlights major gaps in vaccine safety research and post-market surveillance.
President Trump signed an executive order to restore mental institutions across the United States, reversing decades of deinstitutionalization. The move aims to address homelessness, public safety, and long-neglected mental health care.
Deloitte has quietly embedded itself into state and federal government systems while leaving behind a trail of failed projects, fraud losses, and disrupted public services. Despite repeated audits and catastrophic breakdowns, the firm continues to secure massive taxpayer-funded contracts.
U.S. Health Secretary Robert F. Kennedy Jr. has removed multiple members of the federal commission overseeing the Vaccine Injury Compensation Program, signaling a push to reform what he has called a broken system. The move could lead to major changes in how vaccine injury claims are reviewed, debated, and compensated.


















